Wall Street analysts expect that HealthEquity, Inc. (NASDAQ:HQY) will announce $0.14 earnings per share for the current fiscal quarter, according to Zacks. Eight analysts have provided estimates for HealthEquity’s earnings, with the highest EPS estimate coming in at $0.15 and the lowest estimate coming in at $0.12. HealthEquity also posted earnings of $0.14 per share during the same quarter last year. The firm is scheduled to report its next quarterly earnings report on Tuesday, September 5th.

According to Zacks, analysts expect that HealthEquity will report full-year earnings of $0.58 per share for the current financial year, with EPS estimates ranging from $0.54 to $0.60. For the next fiscal year, analysts expect that the company will post earnings of $0.69 per share, with EPS estimates ranging from $0.63 to $0.76. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of analysts that cover HealthEquity.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, June 6th. The company reported $0.19 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.03. HealthEquity had a net margin of 17.04% and a return on equity of 11.61%. The business had revenue of $55.40 million for the quarter, compared to analyst estimates of $54.77 million. During the same period last year, the business posted $0.15 earnings per share. The firm’s quarterly revenue was up 25.9% on a year-over-year basis.

A number of research analysts have issued reports on the stock. Zacks Investment Research downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a research report on Friday. BidaskClub downgraded shares of HealthEquity from a “hold” rating to a “sell” rating in a research report on Thursday. TheStreet raised shares of HealthEquity from a “c” rating to a “b” rating in a research report on Monday, July 31st. Cantor Fitzgerald boosted their price objective on shares of HealthEquity from $55.00 to $56.00 and gave the company an “overweight” rating in a research report on Wednesday, July 5th. Finally, Oppenheimer Holdings, Inc. reissued an “outperform” rating and set a $61.00 price objective (up from $57.00) on shares of HealthEquity in a research report on Monday, June 12th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company. HealthEquity currently has an average rating of “Buy” and an average target price of $50.22.

WARNING: “HealthEquity, Inc. (HQY) Expected to Announce Earnings of $0.14 Per Share” was first posted by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of US and international copyright laws. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/08/07/healthequity-inc-hqy-expected-to-announce-earnings-of-0-14-per-share.html.

Shares of HealthEquity (NASDAQ:HQY) traded up 1.22% during midday trading on Monday, hitting $47.34. 119,045 shares of the company were exchanged. The firm has a market capitalization of $2.84 billion, a price-to-earnings ratio of 88.98 and a beta of 1.73. The firm’s 50 day moving average price is $49.82 and its 200 day moving average price is $46.16. HealthEquity has a one year low of $28.12 and a one year high of $54.95.

In other news, insider Stephen Neeleman sold 40,000 shares of the business’s stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $48.36, for a total transaction of $1,934,400.00. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, major shareholder Berkley Capital, Llc sold 72,791 shares of the business’s stock in a transaction on Friday, July 14th. The shares were sold at an average price of $51.41, for a total transaction of $3,742,185.31. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 2,440,821 shares of company stock worth $125,325,268. Company insiders own 19.00% of the company’s stock.

Several hedge funds have recently made changes to their positions in HQY. Vanguard Group Inc. boosted its position in shares of HealthEquity by 6.2% in the first quarter. Vanguard Group Inc. now owns 4,115,237 shares of the company’s stock worth $174,691,000 after buying an additional 240,136 shares during the last quarter. Glen Harbor Capital Management LLC boosted its position in shares of HealthEquity by 0.4% in the first quarter. Glen Harbor Capital Management LLC now owns 43,956 shares of the company’s stock worth $1,866,000 after buying an additional 154 shares during the last quarter. Paloma Partners Management Co purchased a new position in shares of HealthEquity during the first quarter worth about $503,000. Quantbot Technologies LP boosted its position in shares of HealthEquity by 83.4% in the first quarter. Quantbot Technologies LP now owns 6,883 shares of the company’s stock worth $292,000 after buying an additional 3,129 shares during the last quarter. Finally, Pier Capital LLC purchased a new position in shares of HealthEquity during the first quarter worth about $5,708,000. Hedge funds and other institutional investors own 90.26% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Get a free copy of the Zacks research report on HealthEquity (HQY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.